Members of the NF-kB family of transcription factors function as dominant regulators of inducible gene expression in almost all cell types in response to a broad range of stimuli, with particularly important roles in coordinating both innate and adaptive immunity. This review summarizes the present knowledge and recent progress toward elucidating the numerous regulatory layers that confer target-gene selectivity in response to an NF-kB-inducing stimulus.
The discovery of the transcription factor NF-κB a quarter of a century ago was a major landmark in the study of eukaryotic transcriptional regulation 1 . This discovery was considered to be of great importance because NF-κB represented the first well-documented example of a transcription factor whose binding to DNA is induced by a posttranslational mechanism. Although many other transcription factors induced by post-translational modification or regulation have now been identified, NF-κB has remained at the forefront of the transcription field because of its dominant role in regulating inducible gene transcription in almost all mammalian cell types in response to a wide range of external, internal and environmental cues. To allow NF-κB to make such broad contributions, powerful mechanisms have evolved to ensure that only a limited number of potential target genes are induced when NF-κB's DNA-binding activity is activated in response to a defined stimulus in a specific cell type. A broad framework for understanding NF-κB selectivity and recent progress toward the elucidation of selectivity mechanisms are the focus of this review.
Overview of NF-kB specificity mechanisms Numerous regulatory layers contribute to the cell-type and stimulus specificity of the NF-κB response (Fig. 1) . These layers can be divided into two fundamentally distinct yet interconnected categories: those implemented during the development of a responsive cell type, and those that contribute to specificity of the response when a cell encounters a stimulus. In the first category, recent studies suggest that the cell-type specificity of the NF-κB response is intimately linked to the pathways and factors that control lineage specification and development. For example, transcriptional enhancers for many genes that will be susceptible to NF-κB-induced activation in a differentiated cell become occupied by key developmental regulators in immature cells, perhaps at the time of lineage specification or commitment 2, 3 . Occupancy by transcription factors may result in the assembly of a chromatin structure that is permissive to transcriptional activation. Another regulatory strategy in this first category is the deposition of chromatin barriers at specific sets of NF-κB target genes during development [4] [5] [6] [7] . These barriers dictate which target genes will be activated in response to a stimulus; activation of each gene may depend on whether the stimulus can or cannot promote the elimination of its chromatin barriers. A third strategy through which development can contribute to the cell-type specificity of the NF-κB response is the developmentally controlled activation or repression of signaling molecules and transcription factors that participate in the response to a stimulus and thereby help dictate which NF-κB target genes will be activated (or repressed; for example, ref. 8). Thus, developmental events can act either in cis, by directly altering NF-κB-responsive loci, or in trans, by influencing the expression of factors that may participate in the response after differentiation.
The second category of regulatory layers, those that contribute to specificity when a differentiated cell encounters a stimulus, is remarkably diverse. As described above, chromatin is one central contributor to specificity, as different sets of potential NF-κB target genes have different chromatin barriers that must be eliminated to allow efficient transcription. A given stimulus may induce pathways able to remove some chromatin barriers but not others, which limits the NF-κB response to those genes whose barriers have been successfully eliminated. Some chromatin barriers, such as stable nucleosomes that confer a requirement for nucleosome remodeling, may represent intrinsic properties of a promoter or enhancer and therefore may be largely invariable among cell types for a given gene 9 . In contrast, other barriers, as suggested above, are probably established during development and therefore may differ among cell types. As one example, the promoters for a subset of NF-κB target genes in mouse macrophages have repressive dimethylation of histone H3 at Lys9 (H3K9me2) that, before transcriptional activation, must be eliminated through the action of the H3K9me2 demethylase Aof1 (refs. 4,7) ; the H3K9me2 mark found in unstimulated macrophages is probably deposited during the development of some, but perhaps not all, cell types. Through this mechanism, development may help dictate which genes in a given cell type will require a particular molecular event (in this example, demethylation of H3K9me2) for transcriptional activation, and this event may be catalyzed by some stimuli but not others.
In the model described above linking chromatin barriers established during development to stimulus-dependent pathways that are able to eliminate the barriers, it is important to emphasize that the specific DNA sequence in the control regions of each NF-κB target gene is ultimately responsible for dictating how that gene is regulated. To establish a chromatin barrier at only a subset of r e v i e w 6 9 0 VOLUME 12 NUMBER 8 AUGUST 2011 nature immunology genes, for example, sequence-specific DNA-binding proteins must recognize DNA motifs in the vicinity of those genes and recruit the machinery that establishes the barrier. Similarly, the removal of a chromatin barrier probably requires recruitment of the necessary machinery by other transcription factors able to recognize specific sequences. The possible role of noncoding RNAs in sequencespecific recognition at transcriptional control regions also requires further exploration 10, 11 . Thus, although it is important to characterize the chromatin barriers and the chromatin-remodeling and chromatin-modification machinery that contribute to specificity of the response, an equally critical goal for the future is to identify the sequence-specific recognition events responsible for the establishment and elimination of barriers at key NF-κB target genes. NF-κB may participate in some sequence-specific recognition events linked to chromatin dynamics, but other transcription factors are probably involved when chromatin is used to confer specificity to the NF-κB response. Although chromatin seems to be one central contributor to specificity, there are several additional stimulus-dependent regulatory layers that are of equal importance. One is the frequent, if not universal, need for synergy between NF-κB and other transcription factors that bind DNA motifs in the promoter or enhancers of a given target gene. These additional factors may be inducible, cell type specific or expressed ubiquitously. The enhanceosome complex for the gene encoding interferon-β, which includes several transcription factors induced by viral infection (NF-κB, ATF-2-c-Jun, and IRF3 or IRF7), represents a well-characterized example of transcription factor synergy [12] [13] [14] . Another regulatory layer involves stimulus-dependent post-translational modifications of NF-κB family members, which, at least in some cases, help relieve autoinhibition of DNA binding and support interactions with coregulatory proteins that are needed for the proper induction of defined sets of target genes [15] [16] [17] [18] [19] [20] . Coregulatory interactions can influence multiple steps in gene transcription, including transcription initiation, transcription elongation and RNA processing 21, 22 .
The specificity of an NF-κB response can be influenced further by the five members of the NF-κB family, which can assemble into several dimeric species 23 , raising the possibility that specific dimers are activated by defined signaling pathways and physiological conditions, with each dimer being involved in the regulation of a unique set of target genes. Dimer specificity has been difficult to study because of considerable redundancy between dimeric species and because each NF-κB family member can participate in many different dimers. Nevertheless, the RelB-p52 heterodimer activated by the noncanonical pathway provides one clear example of an NF-κB dimer activated by a unique set of stimuli via a unique pathway, which most probably results in the activation of a unique set of target genes 24, 25 .
One additional contributor to the specificity of the NF-κB transcriptional response is activation kinetics. It is well established that the duration of NF-κB activation and the timing of its subsequent inactivation by export from the nucleus or degradation vary widely in a stimulus-specific manner. This variability can lead to substantial differences not only in the kinetics of target gene expression but also in the sets of target genes induced in response to a stimulus 24, [26] [27] [28] [29] [30] [31] [32] .
In addition to the many mechanisms that help dictate which NF-κB target genes are activated in a particular cell type in response to a given stimulus, powerful mechanisms have evolved to limit the magnitude of induction of NF-κB target genes and to attenuate the response (covered in more detail by Ruland in this issue) 33 . As with the basic specificity mechanisms, regulation of induction magnitude and attenuation can be achieved at many levels. For example, wellestablished regulators of chromatin structure, such as the Mi-2-NuRD nucleosome-remodeling complex and the transcription factor Bcl-6, limit the magnitude of induction of specific subsets of NF-κB target genes in macrophages through mechanisms that have not been fully elucidated 34, 35 . The magnitude of induction of specific target genes is also influenced by intrinsic differences in mRNA stability and by the active regulation of mRNA stability and translation, by microRNAs and proteins that bind 3′ untranslated regions [36] [37] [38] . Finally, the duration of the NF-κB response can be regulated by a wide variety of feedback and attenuation mechanisms, ranging from the transcriptional upregulation of the gene encoding the NF-κB inhibitor IκBα and specific microRNA genes to the feedback inhibition of signaling pathways and the direct repression of target-gene promoters and enhancers 33, 37, 38 .
The remaining sections of this review highlight in greater depth three areas in which recent advances have led to novel conceptual insights into mechanisms that regulate the specificity of the NF-κB response. Other NF-κB-specificity mechanisms have been discussed in detail elsewhere 25, 27, 30, 31, [39] [40] [41] [42] [43] . It is important to emphasize that although this review focuses mainly on the dynamic events that occur at NF-κB target genes in the context of chromatin in the nucleus, the activation of signal-transduction pathways at the plasma membrane and in the cytoplasm-in a stimulus-and cell type-specific manneroften acts upstream of these events to regulate NF-κB specificity. This topic is covered in greater depth by Ghosh and colleagues in this issue 20 . That is, although the precise DNA sequence at the control regions of each gene ultimately dictates which chromatin events, NF-κB dimers, synergistic transcription factors, post-translational modifications and coregulatory interactions participate in proper Figure 1 Contributors to the selectivity of the NF-κB response. The selectivity of the NF-κB response is regulated by many events that take place during the development of a responsive cell type and by a broad range of events that act after stimulation. • Lineage-specific deposition of chromatin barriers
• Activation or repression of signaling molecules and transcriptional regulators that dictate responsiveness to a stimulus regulation, all of these factors are dependent on and coordinated by the precise set of signaling pathways induced by a given stimulus. Thus, full understanding of NF-κB specificity will require in-depth studies of both signal transduction and transcription, along with successful merging of the two disciplines.
Establishing competence for an NF-κB response One exciting advance toward understanding the cell-type specificity of an NF-κB response has emerged from genome-wide studies linking lineage specification and development to stimulus-dependent gene transcription. It has long been known that at control regions for genes expressed only in a differentiated cell type, chromatin changes and binding of transcription factors can be detected early in development, long before the gene is transcribed 44 . Studies of the loci encoding mouse albumin and chicken lysozyme provided early examples of this concept [45] [46] [47] . Although important insights have emerged from studies of individual model genes, genome-wide studies have shown that key regulators of lineage commitment, specification and development orchestrate cell type-specific gene transcription and the cell-type specificity of inducible transcription. In one study, Ghisletti et al. used a chromatinimmunoprecipitation massively parallel sequencing approach (ChIP-Seq) to identify genomic sites that associate with the p300 transcriptional coactivator in lipopolysaccharide (LPS)-stimulated mouse macrophages, toward the goal of identifying LPS-induced enhancers 2 . Strikingly, many of the putative enhancers were found to be associated in unstimulated macrophages with PU.1, a key regulator of myeloid and B cell development 42, 43, 48 (Fig. 2) . In an independent study, Heinz et al. showed that in myeloid cell progenitors, PU.1, along with other key regulators of myeloid development, binds thousands of putative enhancers linked to myeloid-specific genes 3 . In contrast, in B cell progenitors, PU.1 binds with other key regulators of B lymphopoiesis to a distinct set of genomic sites linked to genes expressed in B lineage cells. Other ChIP-plus-microarray and ChIP-Seq studies have provided additional insights into the orchestration of B cell development on a genome-wide scale [49] [50] [51] .
The studies by Ghisletti et al. and Heinz et al. showed that occupancy of the putative enhancers by transcription factors is associated with local changes in chromatin structure, as such regions generally show low nucleosome density after PU.1 binding, suggestive of eviction or repositioning of the nucleosome 2, 3 (Fig. 2) . PU.1 binding (in concert with the binding of other developmental regulatory proteins) also promotes the monomethylation of H3K4 (H3K4me1); this histone modification is often associated with active enhancers 52 . The function of the H3K4me1 mark is not known, but the presence of this mark at the genomic regions analyzed in these studies supports the hypothesis that they correspond to enhancers.
The findings noted above suggest that key developmental regulators are directly responsible for dictating which genes can be expressed in a lineage and which genes are permissive to inducible transcription when differentiated cells subsequently encounter a stimulus. One of several unanswered questions is whether the marking of enhancers at an early stage of development induces chromatin changes only locally (that is, in the vicinity of the enhancer), throughout the locus, or perhaps only at the enhancer and other controls regions for the gene through the formation of an active chromatin hub 53 . The early enhancer interactions could also help position genes in close proximity to appropriate subnuclear locations that confer competence for transcriptional activation.
Studies of one enhancer that seems to conform to the above principles, an enhancer for the mouse gene encoding interleukin 12β (Il12b), located 10 kilobases upstream of the Il12b transcriptional start site 54 , have provided further insight into the mechanisms by which enhancers for NF-κB target genes may be regulated during development and cell activation. The ChIP-Seq data sets of Ghisletti et al. 2 and Heinz et al. 3 demonstrate that the Il12b enhancer is associated with PU.1 and H3K4me1 in both unstimulated and stimulated macrophages, with binding of p300 observed only in stimulated cells. However, this enhancer is probably associated with transcription factors even at a pluripotent stage, as the enhancer has a 'window' of unmethylated CpG dinucleotides in mouse embryonic stem cells 55, 56 (Fig. 2) . This unmethylated window, which is retained throughout development, probably results from the binding of transcription factors during pluripotency. Thus, the Il12b enhancer, and perhaps others, may first be marked in pluripotent cells, which possibly provides competence for the binding of PU.1 and other lineage-specifying factors in myeloid progenitors.
Furthermore, although PU.1 and H3K4me1 are observed at the Il12b enhancer in unstimulated macrophages, hypersensitivity to DNase I, suggestive of extensive chromatin accessibility, is observed only in stimulated cells 54 . Consistent with the stimulus-dependent hypersensitivity to DNase I, SWI-SNF nucleosome-remodeling complexes seem to be recruited to the enhancer only after macrophage stimulation 34 . Thus, although binding of transcription factors in early progenitors may alter nucleosome structure at the enhancer to some extent, the substantial changes in structure associated with hypersensitivity to DNase I may occur only in differentiated cells in response to a stimulus. Genomewide studies of DNase I hypersensitivity and other studies are needed to further elucidate the mechanisms by which enhancers for NF-κB target genes contribute to induction and the specificity of the response. Figure 2 Enhancers for NF-κB target genes may acquire competence for activation at early stages of development. Events that seem to occur at enhancers for NF-κB target genes during development are presented here. Enhancers for some inducible genes seem to be associated with transcription factors in pluripotent cells, which may keep CpG dinucleotides in an unmethylated state and serve as placeholders during the earliest stages of development. During early stages of development, key transcription factors involved in lineage commitment, specification or development, such as PU.1 in cells of the myeloid and B lineages, seem to bind the enhancers and induce local chromatin changes (histone H3K4me1 and nucleosome repositioning) that may confer competence for transcriptional activation in differentiated cells. As the differentiated cell responds to a stimulus, NF-κB and other inducible transcription factors bind the enhancer and recruit essential coactivators, such as p300. The enhancer complex is then thought to interact with the gene's promoter, which also binds constitutive, lineagespecific and inducible transcription factors, including NF-κB, thereby promoting the cascade of events that culminates in transcription initiation and elongation. ESC, embryonic stem cell; MeCpG, methylated CpG. r e v i e w 6 9 2 VOLUME 12 NUMBER 8 AUGUST 2011 nature immunology
Different contributions of chromatin
The studies of Ghisletti et al. 2 and Heinz et al. 3 have shown that developmental events can establish competence for transcriptional activation in response to an NF-κB-inducing stimulus. However, development may also be accompanied by the deposition of chromatin barriers, with different barriers deposited at different subsets of genes. As discussed above, transcriptional activation may then be limited to genes that constitutively lack chromatin barriers and genes whose chromatin barriers can be eliminated by the pathways activated by a given stimulus. Among the chromatin barriers that have been suggested to limit the activation of specific subsets of NF-κB target genes are H3K9 methylation, H3K27 methylation and the simple presence of stable nucleosomes at promoters [4] [5] [6] [7] 9 .
Many additional barriers to activation will probably be identified in the future. Notably, chromatin can contribute to the selectivity of the NF-κB response, not just by providing barriers that must be eliminated for transcriptional activation but also by assisting with molecular events that are needed for efficient gene expression. This is exemplified by a study that began with the discovery of a small-molecule inhibitor of a class of histone-binding proteins known as BRD proteins 57 . These proteins, which include BRD2, BRD3 and BRD4, correspond to a subclass of bromodomain-containing proteins, which bind histones acetylated on specific N-terminal residues [58] [59] [60] . The acetyl-histonebinding pocket of BRD proteins has been found to be suitable for the design of highly selective small-molecule inhibitors 57 . Interestingly, the BRD inhibitor potently suppresses transcriptional activation of only a subset of NF-κB target genes in LPS-stimulated macrophages 57 . The sensitive genes tend to be those with promoters that lack CpG islands, which seem to assemble into stable nucleosomes, thereby conferring a requirement for SWI-SNF nucleosome-remodeling complexes for their activation 9 . In contrast, genes that lack a nucleosome barrier because of the presence of a CpG island-containing promoter are largely resistant to the BRD inhibitor 57 .
BRD proteins are thought to serve as a bridge between histone modifications and P-TEFb, a facilitator of transcription elongation and RNA processing 22, [58] [59] [60] . This connection raises the question of whether the selective effect of the BRD inhibitor might be due to the requirement for P-TEFb at only a subset of NF-κB target genes or, alternatively, to the recruitment of P-TEFb or BRD proteins to different subsets of NF-κB target genes by different mechanisms. Although this question cannot yet be fully answered, the results so far suggest that the selectivity may be due to different mechanisms for the recruitment of BRD proteins and P-TEFb rather than to variable requirements for these proteins. Knockdown of BRD proteins has been found to diminish the transcriptional induction of genes that are resistant to the small-molecule BRD inhibitor, which suggests that BRD proteins are important for transcription of both inhibitorsensitive and inhibitor-resistant genes 22, 57 . Furthermore, an independent study has suggested that BRD proteins can be recruited to some NF-κB target genes by interaction with NF-κB itself rather than by a direct interaction with acetylated histones 61 .
Together, the results noted above suggest that BRD proteins and P-TEFb may be important for the efficient transcription of most or all NF-κB target genes. Although acetylation of the histone H4 residues involved in the recruitment of BRD4 (H4K5, H4K8 and H4K12) is potently induced at genes that are resistant to the BRD inhibitor 22, 57 , BRD4 may be recruited to these genes by two redundant mechanisms-recruitment by NF-κB and recruitment by acetylated histone H4-which may explain the resistance of these genes to the BRD inhibitor.
NF-kB post-translational modifications
It has long been appreciated that NF-κB subunits can be covalently modified in stimulated cells. It is also widely appreciated that transcriptional activation by NF-κB generally requires interactions with transcriptional coactivators, which can influence chromatin structure or other events required for transcriptional activation. Undoubtedly, these two topics are closely linked, as NF-κB modifications will often regulate interactions with coregulatory proteins. All NF-κB family members seem to be extensively modified under physiological conditions, and the list of modifications and coregulatory interactions is expanding more rapidly than ever [15] [16] [17] [18] [19] [62] [63] [64] [65] [66] [67] [68] .
Notably, post-translational modifications of NF-κB dimers and coregulatory interactions that may or may not depend on the post-translational modifications probably have a major role in the specificity of the NF-κB response. Some cell stimuli may activate signal-transduction pathways that promote a specific posttranslational modification of an NF-κB subunit, whereas other stimuli that efficiently catalyze the nuclear translocation of NF-κB may not promote that post-translational modification. Those NF-κB target genes that require the post-translational modification (and the hypothetical coregulatory interaction that is dependent on this modification) for their transcriptional activation will be activated only in response to stimuli that promote the modification, whereas target genes that do not require modified NF-κB may be activated by a broader range of stimuli.
A post-translational modification or a coregulatory interaction may contribute to the activation of only a subset of NF-κB target genes for any of a variety of reasons. First, as with the histone H3K9 demethylase Aof1 or the SWI-SNF nucleosome-remodeling complexes discussed above 7, 9 , a coregulatory interaction may help overcome a chromatin barrier that is present at only a subset of NF-κB target genes. Second, the coregulatory protein may contribute to a step in the transcriptionactivation pathway that is essential at only a subset of NF-κB target genes; activation of other target genes may proceed via fundamentally different pathways that involve, for example, different sets of general transcription factors 69 . Third, as suggested above for BRD proteins and P-TEFb, the same coregulatory protein may be recruited to different sets of target genes via different mechanisms, allowing NF-κB target genes to have different requirements for the post-translational modification. Fourth, a different coregulatory protein recruited via a different mechanism may carry out the same function at a subset of NF-κB target genes.
The selective functions of NF-κB post-translational modifications and coactivator interactions are best exemplified by one of the first NF-κB post-translational modifications to be described: phosphorylation of mouse NF-κB subunit RelA (p65) at Ser276. This phosphorylation event, catalyzed by cyclic AMP-dependent protein kinase, promotes a conformational change that relieves autoinhibition of the DNAbinding activity of RelA and allows RelA to interact with the transcriptional coactivators p300 and CBP 16, 17 . In addition to producing an intriguing epigenetic phenotype, targeted mutagenesis of RelA Ser276 in the mouse germline led to a severe defect in the activation of only a subset of NF-κB target genes in fibroblasts stimulated with tumor necrosis factor 18 . Presumably, the RelA-p300-CBP interaction is required at only a subset of NF-κB target genes for one of the reasons listed above, although the precise reason remains to be elucidated. Targeted mutations that disrupt other post-translational modifications will be needed in the future for better understanding of how the many modifications that have been documented contribute to the complex regulation of NF-κB target genes in various physiological settings.
Although most post-translational modifications of NF-κB family members are thought to contribute to transcriptional induction, it has been reported recently that RelA is monomethylated at Lys310 specifically in unstimulated cells, which has led to the suggestion that this methylation event contributes to tonic repression of a subset of NF-κB target genes 19 . The protein methyltransferase SETD6 is responsible for Lys310 methylation in unstimulated cells, and Lys310 methylation is observed specifically on the small fraction of nuclear, chromatinassociated RelA found before stimulation. RelA monomethylated on Lys310 binds the ankryin-repeat domain of GLP, a partner of the G9a histone H3K9 methyltransferase, leading to evidence that Lys310-methylated RelA promotes H3K9 methylation and active repression of a subset of NF-κB target genes 70 . Interestingly, Lys310 is immediately adjacent to Ser311, previously shown to be phosphorylated by protein kinase C-ζ in cells stimulated with tumor necrosis factor 71 . Phosphorylation of Ser311 blocks the binding of GLP to RelA, which represents a possible mechanism by which RelA-mediated repression is relieved. In the future, it will be helpful to determine whether this proposed regulatory pathway affects precisely the same set of NF-κB target genes that require the Aof1 H3K9 demethylase for their activation, as discussed above 7 .
Concluding remarks
Since the discovery of NF-κB 25 years ago, much has been learned about the mechanisms that contribute to the cell-type and stimulus specificity of the NF-κB response, as well as the many mechanisms that refine and attenuate the response. When combined with major technological advances, these insights will facilitate further progress over the next quarter of a century. The availability of genome sequence information and the increasing quality of genomics technologies will be especially important for future advances. The value of ChIP-Seq for monitoring the binding of NF-κB and other regulators of NF-κB target genes on a genome-wide scale has already been documented. In addition, the quantitative and complete analysis of transcriptomes by RNA-Seq will allow investigators to rigorously evaluate the subsets of target genes influenced by various contributors to selective regulation and to develop hypotheses based on common properties of those sets of genes. Despite the value of studies done on a genome-wide scale, many mechanistic insights will emerge only from in-depth analysis of individual model genes. It is now abundantly clear, however, that understanding of the selective regulation of model genes will require studies done when the genes and their control regions are assembled into native chromatin structures.
One fundamental issue that remains poorly understood is why NF-κB seems to be used so frequently as a dominant regulator of inducible transcription. Does it regulate transcription via molecular mechanisms that are fundamentally similar to those used by other transcription factors, as might be suggested by much of the present literature? If so, it may be frequently used as a dominant regulator of inducible transcription simply because a diverse range of cell stimuli evolved signaling pathways to activate NF-κB dimers. However, an alternative scenario is that NF-κB emerged as a common transcription factor for regulating inducible transcription because it influences gene transcription via unique mechanisms that are fundamentally different from the mechanisms used by most other transcription factors. High-resolution singlecell imaging studies have provided advances toward understanding the dynamic activity of NF-κB, which may ultimately identify key properties that distinguish it from other inducible transcription factors [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] .
A final goal for the future is to take advantage of the accumulated knowledge of NF-κB selectivity mechanisms to develop therapeutic strategies for the treatment of diseases in which NF-κB participates, including cancer and a wide variety of inflammation-related disorders 72 . Because of its broad functions in normal physiology, NF-κB may not itself be an ideal therapeutic target. However, sophisticated understanding of the strategies used to confer specificity on the NF-κB response may suggest strategies for the therapeutic modulation of individual NF-κB target genes or select subsets of target genes.
